Specifications \[*standardized info for the reader*\]Organism/cell line/tissueHuman primary cell populations from\
 • bone marrow-derived mesenchymal stromal cells (bmMSCs)\
 • placental-derived mesenchymal stromal cells (pMSCs)\
 • human cord blood-derived unrestricted somatic stem cells (USSCs)SexMale and femaleSequencer or array typeHuman whole-genome Illumina Human-Ref8 version 2 BeadChips (Illumina, Inc.)Data formatBoth raw and normalizedExperimental factorsTissue comparisonExperimental featuresVery brief experimental descriptionConsentLevel of consent allowed for reuse if applicableSample source locationCity, country of model organism and/or latitude and longitude (and GPS coordinates) for collected samples if applicable

Direct link to deposited data {#s0010}
=============================

<http://www.ebi.ac.uk/arrayexpress/experiments/E-TABM-880/>

<http://www.stemformatics.org/datasets/view/6064>

Experimental design, materials and methods {#s0015}
==========================================

Isolation and culture of cells {#s0020}
------------------------------

### USSCs {#s0065}

Cord blood was collected with informed consent from healthy mothers undergoing elective Caesarean section. The protocol was approved by the University of Melbourne and the Royal Women\'s Hospital Human Ethics Review Committees. A USSC population was successfully generated as described by Kögler et al., 2004. The phenotype of this population has previously been published [@bb0005], [@bb0010]. Cells from passages 5--8 were used in this study.

### bmMSCs and pMSCs {#s0070}

Human bone marrow was obtained from healthy donors after informed consent. Placentas were obtained from healthy mothers during routine elective Caesarean section births at or near term. Full informed consent was obtained. The protocols used to obtain bone marrow and placental MSCs have been described [@bb0015], [@bb0020]. Cells from passages 4--6 were used in this study. Protocols for the isolation and use of each population were approved by the Mater Health Services Human Ethics Review Committee, Brisbane.

Differentiation assays {#s0025}
----------------------

### Osteogenic lineage {#s0075}

Cells were cultured for 21 days in medium containing 10--7 M dexamethasone, 10 mM glycerol-2-phosphate disodium salt (Sigma) and 50 μg/ml ascorbic acid 2 phosphate (Sigma). Cells were fixed for 10 min with 70% ice-cold ethanol at 4 °C and stained with 1% Alizarin Red S (Sigma) in distilled water, pH 4.2. After cells were washed in distilled water and a final wash with PBS (Ca^2 +^ and Mg^2 +^ free), images were captured using a Leica DMIRB inverted microscope and AxioVision 4.2 software (Carl Zeiss AG, [www.zeiss.com](http://www.zeiss.com){#ir0070}).

### Adipogenic lineage {#s0080}

Cells were cultured in medium containing DMEM, 1 μM dexamethasone (Sigma), 5 μg/ml insulin (Sigma), 60 μM indomethacin (Sigma) and 0.5 mM 3-isobutyl-1-methylxanthine (IBMX; Sigma) for 14 days. Adipogenic differentiation was assessed by staining cells with Oil Red O (Sigma).

Flow cytometry {#s0030}
--------------

To detect the presence of cell surface antigens, cells were washed in PBS and detached from flasks using TrypLE Select (Invitrogen). Cells were incubated for 20 min at 4 °C with monoclonal antibodies to CD29, CD31, CD34, CD44, CD45, CD49d, CD49e, CD50, CD73, CD90, CD105, CD146, CD166, GD2, Stro-1, SSEA-4, TRA-1-60 and TRA-1-81, CCR1, CCR3, CCR5, CCR8, CCR10, CCR11, CXCR3, and CXCR4 (BD Biosciences). Flow cytometry analysis was performed on an LSR II (Becton Dickinson) and analyzed using FCS Express software (De Novo, [www.denovosoftware.com](http://www.denovosoftware.com){#ir0075}). To detect the presence of intracellular chemokine receptors, cells were fixed in 4% paraformaldehyde in PBS for 10 min and washed in staining buffer (300 × *g*, 5 min, 4 ° C) before being permeabilized with Fix/Perm buffer (eBioscience, California, USA) for 30 min at 4 °C in the dark. This solution was removed and the permeabilized cells were then stained for the intracytoplasmic expression of chemokine receptors using the antibodies listed above.

Gene expression profiling {#s0035}
-------------------------

### RNA extractions {#s0085}

Total RNA was extracted at passages 4--6 from human bmMSCs, pMSCs and USSCs, using 4 separate donors for each. RNA was extracted using a Qiagen RNeasy kit ([www.qiagen.com](http://www.qiagen.com){#ir0080}). All RNA preparations were quantified using a Nanodrop spectrophotometer (Thermo Scientific) and quality was accessed using an Agilent 2100 Bioanalyser (RNA Nano chips). The RNA integrity number ranged between 9.9 and 10, demonstrating high quality starting material.

### Sample labeling and scanning {#s0090}

Five hundred nanograms of RNA was amplified using the Ambion Illumina RNA amplification kit with biotin UTP labeling (Ambion, Inc), including a 4 h in vitro transcription using T7 RNA polymerase. A total of 750 ng of cRNA was hybridized to human whole-genome Illumina Human-Refseq8 v2 BeadChips (Illumina, Inc.). Slides were scanned on an Illumina Beadstation and bead summarization was performed using BeadStudio Version 3.1.7 (Illumina, Inc). The microarray data are available on the ArrayExpress database ([www.ebi.ac.uk/arrayexpress](http://www.ebi.ac.uk/arrayexpress){#ir0085}) under accession number E-TABM-880. Additionally, the data have been integrated into a public portal, Stemformatics [@bb0025]. Here all the microarray data can be visualized and compared to 100 + other stem cell datasets (<http://www.stemformatics.org>).

### Data normalization and filtering {#s0095}

Data were exported from BeadStudio with no additional processing, and imported to R/BioConductor using the readBead function from the BeadExplorer package. Background adjustment and quantile normalization was performed using function: bg.adjust and normalize.quantiles. Genes were initially filtered using Illumina® detection *p*-value. A gene/probe was included in QC assessment if it had a detection *p*-value ≥ 0.99 all four donor samples within the tissue source.

Results {#s0005}
=======

Cell surface antigen phenotyping {#s0040}
--------------------------------

Based on a standard panel of MSC-descriptive antibodies, all the lines were virtually identical. All expressed CD29, CD44, CD49d, CD49e, CD73, CD90, CD105, CD146, CD49e and CD166 ([Table 1](#t0005){ref-type="table"}). All three cell populations were negative for Stro-1, CD45, CD34, CD50, CD106, and the pluripotency markers SSEA-4, TRA-1-60 and TRA-1-81 ([Table 1](#t0005){ref-type="table"}).

Chemokine receptor display {#s0045}
--------------------------

The surface and intracellular chemokine displays of bmMSCs and pMSCs were very similar. USSCs differed from bmMSCs and pMSCs by showing positive staining for the presence of intracellular CCR8, CCR10 and CCR11 ([Table 2](#t0010){ref-type="table"}).

Mesodermal differentiation assays {#s0050}
---------------------------------

Typical MSC morphology was confirmed in culture ([Fig. 1](#f0005){ref-type="fig"}), and the mesodermal differentiation potential of each of the three cell populations was assessed in vitro to determine their multipotency ability. This was analyzed according to the cells\' ability to differentiate into osteocytes and adipocytes. All three undifferentiated populations showed marked ability to differentiate to the osteogenic lineage. bmMSCs showed stronger differentiation to the adipogenic pathway that pMSCs and USSCs, each of which showed only a slight degree of adipogenesis ([Fig. 1](#f0005){ref-type="fig"}).

Gene expression quality {#s0055}
-----------------------

Normalization reduced the between array variation ([Fig. 2](#f0010){ref-type="fig"}). Principle component analysis was performed to demonstrate the difference between the MSC sources and the reproducibility of the replicate donors. When plotting on the first two components, the samples clustered based on their tissue source, but some donor variation was apparent ([Fig. 2](#f0010){ref-type="fig"}a). All replicates were tightly clustered except for one USSC sample (Chip ID: 4294077038_D; Sample ID: USSC4). However, this sample was still highly correlated to the other USSC donors (Average Pearson of 0.89) compared to 0.95 for the bmMSCs and pMSCs. When plotting components two and three the samples clustered based on their tissue source ([Fig. 2](#f0010){ref-type="fig"}b).
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![Mesodermal differentiation by MSCs from different sources. Left column: undifferentiated MSCs have a fibroblast-like phenotype, actin stained with phalloidin, and nuclei stained with DAPI. Middle column: calcium-rich matrix produced by osteoblasts is stained with Alizarin Red; right column: lipid droplets in adipocytes were stained with Oil Red O. Rows from top to bottom: MSCs sourced from term placenta (pMSCs), cord blood (USSCs) and bone marrow (bmMSCs). Magnification × 40.](gr1){#f0005}

![QC and principal component analysis of gene expression data (detected probes only): Panel a: comparing components 1 (89.1% variance) and 2 (4.1% variance);\
b: comparing components 2 (4.1% variance) and 3 (2.3% variance). Legend: MSC source indicated by color: pMSCs (green); bmMSCs (red); USSCs (blue).\
c: Range of gene expression and median values in samples pre (left) and post (right) normalization.](gr2){#f0010}

###### 

Cell surface markers on bmMSCs, pMSCs and USSCs.

  Marker association                            CD number/name   Other name                                              bmMSC            hpMSC            USSC
  --------------------------------------------- ---------------- ------------------------------------------------------- ---------------- ---------------- ----------------
  Mesenchymal stromal cell-associated markers   CD29             Integrinβ1                                              Positive         Positive         Positive
                                                CD44             HCAM (homing cell adhesion molecule)                    Positive         Positive         Positive
                                                CD73             Ecto-5′-nucleotidase                                    Positive         Positive         Positive
                                                CD90             Thy-1                                                   Positive         Positive         Positive
                                                CD105            Endoglin                                                Positive         Positive         Positive
                                                CD146            MCAM (melanoma cell adhesion molecule)                  Positive         Not done         Positive
                                                GD2              Neural ganglioside 2                                    Faint staining   Faint staining   Faint staining
  Mesenchymal stem cell-associated marker       Stro-1           Stromal cell molecule-1                                 Negative         Negative         Negative
  Endothelial marker                            CD31             PECAM-1 (platelet/endothelial cell adhesion molecule)   Negative         Negative         Negative
  Hematopoietic cell-associated markers         CD34             Mucosialin                                              Negative         Negative         Negative
                                                CD45             Leukocyte common marker                                 Negative         Negative         Negative
  Other adhesion molecules                      CD49d            VLA-4 (very late antigen-4)                             Positive         Positive         Positive
                                                CD49e            VLA-5a (very late antigen-5a)                           Positive         Positive         Positive
                                                CD50             ICAM-3 (intercellular adhesion molecule)                Negative         Faint staining   Negative
                                                CD166            ALCAM (activated leukocyte cell adhesion molecule)      Positive         Positive         Positive
  Pluripotency markers                          SSEA-4           Stage-specific embryonic antigen-4                      Negative         Negative         Negative
                                                TRA 1-60         TRA (Tumor Rejection Antigen)                           Negative         Negative         Negative
                                                TRA 1-81         TRA (Tumor Rejection Antigen)                           Negative         Negative         Negative

###### 

Chemokine receptor display by bmMSCs, hpMSCs and UCCSs.

  Chemokine receptor   bmMSC surface display   bmMSC intracellular display   hpMSC cell surface display   hpMSC intracellular display   USSC cell surface display   USSC intracellular display
  -------------------- ----------------------- ----------------------------- ---------------------------- ----------------------------- --------------------------- ----------------------------
  CCR1                 Faint staining          Positive                      Faint staining               Positive                      Negative                    Faint staining
  CCR3                 Negative                Positive                      Negative                     Positive                      Negative                    Positive
  CCR5                 Negative                Negative                      Negative                     Negative                      Negative                    Negative
  CCR8                 Faint staining          Negative                      Faint staining               Negative                      Negative                    Positive
  CCR10                Negative                Negative                      Negative                     Negative                      Negative                    Positive
  CCR11                Faint staining          Negative                      Faint staining               Negative                      Negative                    Positive
  CXCR3                Negative                Positive                      Negative                     Positive                      Negative                    Positive
  CXCR4                Positive                Positive                      Positive                     Positive                      Negative                    Positive
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